O53: Can integrated genomic analysis replace chromosomal analysis for the diagnosis of hematological malignancies: Addressing the shortage of cytogenetic technologists

Chromosomal analysis (CA) has been part of the standard care for patients with hematological malignancies since Dr. Nowell and colleague discovered the Philadelphia chromosome in chronic myelogenous leukemia in 1961. CA examines cancer-associated numerical and structural abnormalities at the single-cell level and has played a significant role in leukemia diagnosis, risk stratification, and treatment selection. However, the resolution of CA in detecting chromosomal rearrangements and copy number variations (CNVs) is limited.

Authors

Institutions

Publication Details

Journal
Genetics in Medicine Open
Published
2025-01-01
DOI
https://doi.org/10.1016/j.gimo.2025.102480
Primary Topic
Cancer Genomics and Diagnostics
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

O53: Can integrated genomic analysis replace chromosomal analysis for the diagnosis of hematological malignancies: Addressing the shortage of cytogenetic technologists

Donna Wilmoth, Brian Thiel, Elizabeth Margolskee, Luanne Wainwright et al.
1 links
Genetics in Medicine Open
Cancer Genomics and Diagnostics
article

O53: Can integrated genomic analysis replace chromosomal analysis for the diagnosis of hematological malignancies: Addressing the shortage of cytogenetic technologists

Donna Wilmoth, Brian Thiel, Elizabeth Margolskee, Luanne Wainwright, Stephen P. Hunger, Susan R. Rheingold, Lea F. Surrey, Haley Newman, Minjie Luo, Michele Paessler, Sarah K. Tasian, Marilyn M. Li, Kathrin M. Bernt, Gerald Wertheim, Vinodh Pillai, Dong Li, Yiming Zhong
article en

Abstract

Chromosomal analysis (CA) has been part of the standard care for patients with hematological malignancies since Dr. Nowell and colleague discovered the Philadelphia chromosome in chronic myelogenous leukemia in 1961. CA examines cancer-associated numerical and structural abnormalities at the single-cell level and has played a significant role in leukemia diagnosis, risk stratification, and treatment selection. However, the resolution of CA in detecting chromosomal rearrangements and copy number variations (CNVs) is limited.

Genetics in Medicine OpenVol. 3
Children's Hospital of Philadelphia (US)
Zero hunger
Openalex Percentile: Top 94%
Cancer Genomics and Diagnostics
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.